05:14 , Jun 26, 2019 |  BC Extra  |  Financial News

Spain’s Sanifit heads to Phase III with €72.2M in new funding

With €72.2 million ($82.1 million) in fresh cash to fund a Phase III study of its lead candidate to treat a rare vascular calcification disorder, Sanifit is looking ahead to additional Phase IIb trial results...
20:45 , May 24, 2019 |  BioCentury  |  Finance

Europe: Some spots hotter than others

Led by the U.K., various regions in Europe are raising their profile as hotspots of innovation. But as other areas lose ground, local VCs are raising fresh capital and building the infrastructure needed to boost...
23:21 , May 23, 2019 |  BC Extra  |  Company News

With Merck veterans at the helm, Nektar launches subsidiary for pain compound

Nektar has been signaling for months that it planned to create a subsidiary to house analgesic NKTR-181, with a financial partner on board to fuel a commercial launch. Now that it has launched Inheris, the...